Results 151 to 160 of about 21,238,241 (185)

The diagnostic efficacy of CYFRA21-1 on intrahepatic cholangiocarcinoma: A meta-analysis

Clinics and Research in Hepatology and Gastroenterology, 2019
To evaluate the reliability and accuracy of Cytokeratin-19-fragment (CYFRA21-1) in the diagnosis of intrahepatic cholangiocarcinoma (ICC) based on literature meta-analysis and the diagnostic efficacy and clinical application of CYFRA21-1 in ICC.MEDLINE, China National Knowledge Infrastructure Library and other databases were used to base the inclusion ...
Liao Yuan
exaly   +3 more sources

Serum CYFRA21-1 as a prognostic marker for patients with undifferentiated nasopharyngeal carcinoma

Biomarkers, 2010
The purpose of this study was to evaluate the potential of serum CYFRA21-1 and carcinoembryonic antigen (CEA) as prognostic markers in patients with undifferentiated nasopharyngeal carcinoma. Sixty-one patients who received definitive radiotherapy/chemoradiotherapy were analysed retrospectively.
Jinming Yu
exaly   +3 more sources

Electrochemiluminescent immunoassay for the lung cancer biomarker CYFRA21-1 using MoOx quantum dots

Mikrochimica Acta, 2019
Molybdenum oxide quantum dots (MoOx QDs) were synthesized by a one-pot method and used as a versatile probe in an electrochemiluminescent (ECL) immunoassay of the non-small cell lung cancer biomarker cytokeratin 19 fragment 21-1 (CYFRA21-1) as a model analyte. The MoOx QDs exhibited stable and strong cathodic green ECL, with an emission peak at 535 nm,
Xiangying Meng, Hao-Hua Deng, Luyao Xu   +2 more
exaly   +3 more sources

Multimodality therapy and significance of serum CYFRA21-1 for thymic carcinoma

Oncology Reports, 2005
Thymic carcinoma is a rare mediastinal neoplasm with a poor prognosis due to delayed diagnosis and highly malignant behavior. To evaluate 7 serum tumor markers and the outcome of treatment, 11 stage III-IVb thymic carcinomas undergoing multimodality treatment were reviewed. High levels of serum CYFRA21-1 were detected in 5 patients (45%) and correlated
Makoto, Suzuki, Soichiro, Ando, Tomohiko, Iida, Takehiko, Fujisawa, Hideki, Kimura   +4 more
openaire   +2 more sources

The establishment of detecting cytokerantin 19 fragment(CYFRA21-1) with immunofluorescence chromatography

2017 2nd International Conference on Advanced Robotics and Mechatronics (ICARM), 2017
This study was designed to develop a immunofluorescence chromatography kit for detection of CYFRA21-1 in human serum, and to evaluate the method performance. The fluorescent polystyrene particle conjugated with the monoclonal antibody MIC07 was used as a fluorescent label.
Lin Xia, Jiakun Cao, Sheng Tang
openaire   +1 more source

CEA, CYFRA21-1 and SCC in non-small cell lung cancer

Lung Cancer, 1995
CEA, SCC and CYFRA 21-1 were measured in samples of serum coming from 105 'Non small cell lung cancer' (NSCLC) patients. The present study has been carried out to compare these markers, to analyse their prognostic significance and to determine the best combination of tumor markers.
D, Moro, D, Villemain, J P, Vuillez, C A, Delord, C, Brambilla   +4 more
openaire   +2 more sources

Rapid and quantitative detection of urinary Cyfra21-1 using fluorescent nanosphere-based immunochromatographic test strip for diagnosis and prognostic monitoring of bladder cancer

Artificial Cells, Nanomedicine and Biotechnology, 2019
Bladder cancer is a common malignant tumour with high recurrence rate. Cytokeratin 19 fragments (Cyfra21-1) in urine has been regarded as a promising biomarker for the prognosis and diagnosis of bladder cancer due to the relevance of its high urinary ...
Qifang Lei, Song Wu
exaly   +2 more sources

Perfluorosulfonic acid polymer based eATRP for ultrasensitive detection of CYFRA21-1 DNA

Analytical Methods, 2020
The sensitive detection of biomarker cytokeratin fragment antigen 21-1 (CYFRA21-1) is crucial for early diagnosis and screening of non-small cell lung cancer (NSCLC).
Kai Hu, Jiamin Cheng, Jinge Li, Shan Ye, Huaixia Yang, Yanju Liu, Jinming Kong   +6 more
openaire   +2 more sources

Serum Cytokeratin 19 Fragment (CYFRA21-1) as a Prognostic Factor in Intrahepatic Cholangiocarcinoma

Annals of Surgical Oncology, 2007
A high serum cytokeratin 19 fragment (CYFRA21-1) concentration in patients with various cancers is associated with poor prognosis. This study aimed to establish the clinical significance of preoperative serum CYFRA21-1 in patients with intrahepatic cholangiocarcinoma.CYFRA21-1, carcinoembryonic antigen (CEA), and carbohydrate antigen (CA) 19-9 ...
Takahiro, Uenishi, Osamu, Yamazaki, Hiromu, Tanaka, Shigekazu, Takemura, Takatsugu, Yamamoto, Shogo, Tanaka, Shuhei, Nishiguchi, Shoji, Kubo   +7 more
openaire   +2 more sources

[Clinical usefulness of serum CYFRA21-1 in colorectal cancer].

Gan to kagaku ryoho. Cancer & chemotherapy, 1996
Serum CYFRA21-1 levels were studied in 127 cases of colorectal cancer. The positive rates for serum CYFRA21-1 were 34.6% in primary colorectal cancer. There was a significant correlation between the positive rates of serum CYFRA21-1 and liver metastases, peritoneal dissemination, lymph node metastases, or clinical stage.
T, Miyashita, G, Nishimura, Y, Michiwa, T, Sato, K, Tsugawa, S, Fushida, K, Sugiyama, T, Fujimura, Y, Yonemura, K, Miwa, I, Miyazaki   +10 more
openaire   +1 more source